(Q69579918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

title

5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

author name string

M B Grisham

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

D N Granger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 April 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

573-578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2702889%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01536335

3 October 2019

exact match

0 references

cites work

Kinetics of 5-aminosalicylic acid after jejunal instillation in man.

1 reference

12 December 2020

Intestinal blood flow

1 reference

12 December 2020

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

1 reference

12 December 2020

Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis

1 reference

12 December 2020

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

12 December 2020

Effect of anti-inflammatory drugs on xanthine oxidase and xanthine oxidase induced depolymerization of hyaluronic acid

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion

1 reference

12 December 2020

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

1 reference

12 December 2020

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

12 December 2020

Regulation of colonic blood flow.

1 reference

12 December 2020

Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis

1 reference

12 December 2020

A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid

1 reference

12 December 2020

Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine

1 reference

12 December 2020

The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis

1 reference

12 December 2020

Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle

1 reference

12 December 2020

Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?

1 reference

12 December 2020